Relationship between the Thyroid Function and Cognitive Impairment in the Elderly in Japan.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
15 Oct 2022
Historique:
pubmed: 23 3 2022
medline: 19 10 2022
entrez: 22 3 2022
Statut: ppublish

Résumé

Objective The reference ranges of serum thyroid hormone levels are determined by the values of normal subjects aged 15 or 20 to 60 years old in Japan and may differ from the values in elderly patients. In addition, the relationship between the thyroid function and cognitive function remains controversial. We assessed the thyroid function of elderly subjects ≥60 years old and its impact on the cognitive function in Japanese adults. Methods We compared the thyroid function by age group and gender and investigated the effects of cognitive impairment on the thyroid function. This study was a cross-sectional, multi-institutional joint study. Patients The serum concentrations of thyroid hormones in 1,136 patients were measured; however, those taking thyroid hormones, anti-thyroid drugs, and steroid hormones were excluded. Among them, 1,016 cases in which the cognitive function was evaluated were divided into five groups according to their free thyroxine (FT4) levels. Results Excluding overt thyroid dysfunction (5.8%), the average age of the 1,070 remaining patients was 77.5 years old. The rate of cognitive impairment was lowest at FT4 levels of 1.1-1.2 ng/dL and highest at FT4 levels <0.9 ng/dL for both genders. Thyroid-stimulating hormone (TSH) levels in the elderly varied widely by age group and gender. The upper limit of the reference range of TSH for those ≥60 years old may be higher (7.7-9.2 mIU/L for men; 8.2-8.6 mIU/L for women) than the current range for those <60 years old (4.23 mIU/L). Conclusion The thyroid function seemed to be slightly higher (lower TSH and higher FT4) in the population without cognitive impairment than in those with cognitive impairment, except for men in their 90s.

Identifiants

pubmed: 35314549
doi: 10.2169/internalmedicine.9034-21
pmc: PMC9646354
doi:

Substances chimiques

Thyroid Hormones 0
Thyrotropin 9002-71-5
Thyroxine Q51BO43MG4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3029-3036

Références

Endocr Connect. 2021 Apr 22;10(4):410-421
pubmed: 33875615
JAMA Intern Med. 2021 Nov 1;181(11):1440-1450
pubmed: 34491268
Psychopharmacol Bull. 1988;24(4):689-92
pubmed: 3249771
J Clin Endocrinol Metab. 2014 Feb;99(2):424-32
pubmed: 24285689
J Clin Endocrinol Metab. 2015 Nov;100(11):4240-8
pubmed: 26305618
J Am Geriatr Soc. 1990 Mar;38(3):221-6
pubmed: 2313003
Clin Chem. 2017 Jul;63(7):1248-1260
pubmed: 28522444
J Clin Endocrinol Metab. 2016 Dec;101(12):4945-4954
pubmed: 27689250
Psychoneuroendocrinology. 2019 Jan;99:112-119
pubmed: 30223192
Endocr J. 2009;56(9):1059-66
pubmed: 19738362
Clin Endocrinol (Oxf). 2017 Nov;87(5):617-626
pubmed: 28850708
Neurology. 2016 Oct 18;87(16):1688-1695
pubmed: 27638924
Geriatr Gerontol Int. 2018 Oct;18(10):1458-1462
pubmed: 30225857
Alzheimer Dis Assoc Disord. 1991;5 Suppl 1:S40-8
pubmed: 1781973
J Endocrinol Metab. 2019 Aug;9(4):82-89
pubmed: 32411312
Front Aging Neurosci. 2021 Jul 29;13:696174
pubmed: 34393759
J Clin Endocrinol Metab. 2002 Feb;87(2):489-99
pubmed: 11836274
J Clin Endocrinol Metab. 2013 Mar;98(3):1147-53
pubmed: 23345094

Auteurs

Sumiko Furuto-Kato (S)

Department of Diabetes Mellitus and Endocrinology, Osaka Saiseikai Ibaraki Hospital, Japan.

Atsushi Araki (A)

Department of Diabetes, Metabolism, and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Japan.

Yuko Chiba (Y)

Department of Diabetes, Metabolism, and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Japan.

Michizou Nakamura (M)

Department of Neurology, National Hospital Organization Kyoto Medical Center, Japan.

Mitsuyo Shintani (M)

Department of Diabetes Mellitus and Endocrinology, Osaka Saiseikai Nakatsu Hospital, Japan.

Takashi Kuwahara (T)

Department of Nephrology, Osaka Saiseikai Ibaraki Hospital, Japan.

Hajime Yamakage (H)

Clinical Research Institute for Endocrine and Metabolic Diseases, National Hospital Organization Kyoto Medical Center, Japan.

Noriko Satoh-Asahara (N)

Clinical Research Institute for Endocrine and Metabolic Diseases, National Hospital Organization Kyoto Medical Center, Japan.

Tetsuya Tagami (T)

Clinical Research Institute for Endocrine and Metabolic Diseases, National Hospital Organization Kyoto Medical Center, Japan.
Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH